Clinical Trial Update: Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial of clofarabine with cytarabine in patients with minimal residual disease-positive acute leukemia was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clofarabine (clofarabine)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Minimal Residual Disease, Leukemia, Lymphoblastic, Acute | Phase 2 | Status: TERMINATED | Results posted: 2019-10-07